Today’s top gainers include the company Celgene Corporation (NASDAQ:CELG) which is in the industry Biotechnology, gaining 2.18% today. In the last week its performance is 2.81%, and -1.98% for the past quarter. Currently, Celgene Corporation, CELG has a target price of 136.1, so today’s gain of 2.18% is a significant step towards its target price. The GAP today is therefore 0.94%.
Celgene Corporation (NASDAQ:CELG), has a market cap of 81666.37, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 80.50%.
At the current price of 106.9, it has a dividend yield of *TBA, and its target price is 136.1. This is with a profit margin of 17.40%, and total debt/equity of 0. Celgene Corporation (NASDAQ:CELG) has a P/E of 50.61, as well as a forward P/E of 14.89.
With a current EPS of 2.07, and a forecasted EPS growth for next year at 23.72%,Celgene Corporation (NASDAQ:CELG) has had a EPS growth for the past five years at 15.70%. For the next five years EPS growth is projected to be 22.03%.
Performance for the year is -23.21%. Since its IPO date on 3/26/1990, the total performance to date is -12.64%.
Volume today for Celgene Corporation (NASDAQ:CELG), is 3399250, while its average volume is 4341.04. Whilst the total gain today was 2.18%, it did have a day high of -1.47%.
Volatility for this week has been at 2.05%, and 2.43% for the month. The 52-week low for Celgene Corporation, CELG has been 14.98%, while the 52-week-high has reached -24.03%.
Looking at its return of investments, which is 8.90%, and its return on assets is 6.90%. Celgene Corporation (NASDAQ:CELG) has an operating margin of 24.50%. With a sales growth of 20.70% quarter over quarter. Bearing in mind that Celgene Corporation, CELG is in the sector Healthcare, its long-term debt/equity is 2.81, and has a current ratio of 4.6 and 4.3 for quick ratio.
So what is the value of Celgene Corporation? Well its PEG is 2.3, and the P/S is 8.43, along with a P/B of 16.1. Meanwhile it has a p/cash of 14.31.